NDC 0597-7705 – Spevigo
Spesolimab 300 mg/1 · Injection · Intravenous
Product NDC0597-7705
Product details
- Brand name
- Spevigo
- Generic name
- Spesolimab-sbzo
- Labeler
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- BLA · BLA761244
- Marketed since
- May 28, 2025
- Marketing end
- April 30, 2027
- Pharmacologic class
- Interleukin-36 Receptor Antagonist
Active ingredients
- Spesolimab 300 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0597-7705-41 | 1 SYRINGE in 1 CARTON (0597-7705-41) / 300 INJECTION in 1 SYRINGE (0597-7705-38) | May 28, 2025 |
| 0597-7705-72 | 2 SYRINGE in 1 CARTON (0597-7705-72) / 300 INJECTION in 1 SYRINGE (0597-7705-38) | May 28, 2025 |
Other Spevigo products
- 0597-0035 Spesolimab 60 mg/mL · Injection · Boehringer Ingelheim Pharmaceuticals, Inc.
- 0597-0620 Spesolimab 150 mg/1 · Injection · Boehringer Ingelheim Pharmaceuticals, Inc.
- 50222-360 Spesolimab 60 mg/mL · Injection · LEO Pharma Inc.
- 50222-361 Spesolimab 150 mg/mL · Injection · LEO Pharma Inc.
- 50222-362 Spesolimab 300 mg/2mL · Injection · LEO Pharma Inc.